About Image

About Our Company

ATGenes Co., Ltd. provides services related to molecular genetic testing and medical laboratory diagnosis covering various genetic diseases in man. For example, thalassemia and hemoglobinopathies, a hereditary condition, are commonly found in Thailand and Southeast Asia, the fast growing economic community or ASEAN Economy Community (AEC). More than 40% of the population in this region are carriers or heterozygotes for thalassemia and / or hemoglobin disorders. As an autosomal recessive condition, carriers of thalassemia have a pregnancy risk for their offspring to develop severe forms of thalassemia requiring life-long treatment. Our ATGenes Co., Ltd. has our own technology for a comprehensive diagnosis using DNA technology that covers over 99% of genetic mutations that causes of thalassemia and hemoglobin disorders. Our company also provides services for molecular diagnosis of more than 60 other genetic diseases such as immunodeficiency, metabolic syndromes, hematologic cancers, lung cancer, colon cancer, endocrine neoplasm, breast cancer and genetic diseases related to hemolytic anemia and coagulopathy.

Read More
International Standards
100%
Laboratory Quality
100%
Test Accuracy
100%
Quality of Screening
100%


Main Service of ATGenes

(Pre-Preimplantation genetic diagnosis : Pre-PGD, Pre-Prenatal diagnosis : Pre-PND)

Read More>>

Pre-implantation genetic diagnosis (PGD) and Pre-implantation genetic screening (PGS)

Read More>>

Prenatal molecular diagnosis and Non-invasive prenatal testing (NIPT) by Harmony©

Read More>>

Expanded neonatal (newborn) screening including newborn screening for thalassemia

Read More>>

Future genetic risk assessment and cancer genetic risks (Personalized Cancer Mutation Panel)

Read More>>

Molecular genetic diagnosis for specific genetic conditions and Whole Exome Sequencing (WES)

Read More>>

Molecular genetic testing for cell-free DNA for diagnosis and disease monitoring especially common cancer conditions (Liquid biopsy) (Comprehensive cancer panel)

Read More>>

Paternity DNA testing and individual genetic identification (Paternity test)

Read More>>

Hormonal and serological evaluation for pre-marital screening (Comprehensive pre-pregnancy test)

Read More>>

Nutrigenetic and genetic risk assessment for sport and wellness

Read More>>

Pharmacogenetic and pharmacogenomic tests

Read More>>

Molecular identification for organism causing human diseases

Read More>>

QualityAssurance of Service

Client Testimonials

Latest From The Blog

Blog Image

Precision Medicine Part 4 When people are not just one disease anymore.

This is a long Story (Again) When I was a medical student...

Read More >>
Blog Image

Risk Assessment for Ischemic Heart Disease

It's an ApoE gene testing that lets you know if you have a risk of developing ischemic heart disease.

Read More >>
Blog Image

Is your Fetus has a Down Syndrome risks ?

Avoid from genetic diseases with Harmony Prenatal Test by ATGenes

Read More >>

Frequently Asked Questions

About ATGenes

“ATGenes Co., Ltd. is “the World Class Biotechnology Company”
“Provide a health service based on biotechnology from cradle to grave”
ATGenes™ Co. Ltd. was established on 9 January, 2014 by a group of experienced businessmen together with a group of the World-renown experts on medical science in particular molecular medicine and biotechnology including medical doctors, medical technologists and laboratory scientists who have more than 20 years experience. Our passion is to establish a standard Biotechnology Company” that belongs to Thai people and the Kingdom of Thailand with current international standard to provide the most comprehensive services for disease diagnosis, disease risk assessment, screening and counseling based on advance DNA and molecular bio-logy technology. In addition, ATGenes™ also provides services using the latest medical technology to serve the country and people of Thailand as a local distributor for several high-end medical diagnostic tests and services in order to improve a standard of medical care of Thai people and neighboring countries. Biotechnology is the future business enterprise that will be increasing important for the future of our country and worldwide. ATGenes™ provides comprehensive services for molecular DNA diagnosis for common genetic diseases found in Thailand and Southeast Asia (Southeast Asia), which would become future regional market for ATGenes™ within ASEAN Economy Community (AEC). The most important genetic condition within Thailand and this region is “thalassemia”, an inherited genetic condition that causes chronic hemolytic anemia in which can be variable on clinical severity from mild anemia to life-threatening anemia or lethal in utero. Over 40% of Thai population is carriers for thalassemia and its related condition (hemoglobinopathy). ATGenes™ provides a service based on molecular testing that covers over 99% of molecular mutations causing thalassemia and hemoglobinopathy found in Thailand and AEC countries. In addition, ATGenes™ provides molecular or DNA testing for diagnosis of over 60 genetic conditions such as inborn error of metabolism, inherited immune deficiency syndromes, several oncology and hematology conditions. In addition, ATGenes™ can also serve for diagnosis of genetic risks for common diseases such as coronary artery diseases, osteoporosis and osteopenia, gout, pharmacogenetics such as risk of drug allergy from alloperinol or risk of drug overdose such as 6-mercaptopurine, 6-thioguinine or warferrin etc. This genetic information is now useful and indispensable for life-style modification, disease management and drug-dose adjustment in order to achieve the best benefit from medical treatment. Our know-how on molecular diagnosis and DNA testing has led us to provide additional services on applying this genetic testing to special circumstances such as Pre-implantation Genetic Diagnosis (PGD). We have developed a wide-variety of molecular genetic tests for embryo selection to avoid affected condition using the latest technology such as fluorescence PCR based tests, real-time PCR based analyses and short tandem repeats (STR) marker studies to detect causative mutations in a single cell based analysis. Moreover, we have applied this technology for further embryo selection to identify embryo with possible match human leukocyte antigen (HLA) with previous affected siblings for future treatment such as stem cell transplantation. Beside molecular genetic services, ATGenes™ is also the first company in Thailand that provides comprehensive laboratory services for fetal-maternal health. These include; a comprehensive newborn screening tests for over 46 genetic diseases such as thalassemia, inborn error of metabolism and G6PD deficiency. This newborn screening panel will be similar for those of services offered in all developed countries such as USA, Japan and all European countries. Early identification of these hereditary conditions at birth can prevent awful and horrible outcomes such as mental retardation, neurodevelopment abnormalities and physical disability later on in their life since appropriate medical measures such as early medical intervention, selection of appropriate infant formula products and correct medication can initiated earlier before all damages will start. This service will help to improve the standard of neonatal care in Thailand from, at present, only two diseases; congenital hypothyroidism and phenylketoneurea (PKU) screened, to nearly 50 medical conditions can be early detected early in life. To further compliment with neonatal screening services, ATGenes™ also provides our laboratory services to screen for other genetic conditions, namely chromosomal abnormalities; trisomy. To this regard, there are two services available; one is The Harmony™, the World-class standard Non-Invasive Prenatal Test (NIPT) provided by Ariosa™, USA and our ATGenes™’s prenatal diagnostic panel from maternal serum screening. ATGenes™ is the exclusive distributor for The Harmony™ test that uses the latest DNA technology on next generation sequencing (NGS) to detect trisomy 21 (Down syndrome), trisomy 13 (Patau syndrome) and trisomy 18 (Edward syndrome) together with sex chromosome abnormalities (XXY, XXX, XYY etc.). This test provides over 99% sensitivity and specificity making this test is currently one of the most popular NIPT in the USA and can be tested as early as 10 weeks of gestation. In addition, for those with financial concern, our combined maternal serum screening from the first trimester can be an alternative since our maternal serum markers screening has a high reliability and sensitivity that was proven and used in several clinical trials.
Beside all these molecular and DNA testing services that can serve our customers from their origins (as a fetus) to early in life (neonatal or newborn screening) throughout their life (molecular diagnosis, genetic risk assessment and pre-marital screening), ATGenes™ also has another mission to improve the standard of health care in Thailand using the latest medical laboratory technology. To this regard, ATGenes™ will provide a service as a distributor of several medical products such as a home-based point of care-test (POCT) for hemoglobin, hematocrit and blood glucose in one single device to a simplified serum screening for specific IgE tests for common allergic diseases etc. All these services are only the beginning of our future at ATGenes™. With an increasing knowledge on human diseases and condition through human genome projects and others that our genetic codes have been deciphered and help revolutionized our medical practices, we all at ATGenes™, are committed to provide the latest, state-of-the art medical technology to all people of Thailand and all neighboring countries of AEC in order to improve our standard of healthcare globally from disease prevention, early detection, risk assessment and life-style modification to tailor-made medical treatments. As we all said at ATGenes™ that “Your codes, Your life” and ATGenes™ will help you to understand your ‘genetic codes’ for your better life and better health.

Harmony Prenatal Test

The Harmony Prenatal Test is a DNA-based non-invasive prenatal test (NIPT) for Down syndrome (trisomy 21), trisomy 18 and trisomy 13 using cell free fetal DNA. It is proven to be more accurate than traditional screening tests and can be performed as early as 10 weeks of pregnancy. The Harmony Prenatal Test can also report fetal sex, screen for sex chromosome conditions and 22q11.2 deletion. In addition, we provide prenatal diagnosis for all genetic diseases using chorionic villous, amniocentesis and fetal blood samples.

Contact Us

AtGenes Map

Please Contact With Us For Any Kind Of Information